Interestingly, BRAF (V600E) mutation in melanoma cells does not evidently affect PD-L1 expression; however, PD-L1 expression is attenuated by treatment with BRAF inhibitor, but enhanced when melanoma cells become resistant to BRAF inhibitor [130]. Here, CD274 is linked to melanoma.